261 results on '"Mohammed, Abdul Rasheed"'
Search Results
2. Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist: Results from the phase 2 double-blind randomized placebo-controlled study for the treatment of excessive daytime sleepiness in adult patients with narcolepsy
3. Medicinal and Aromatic Plants of India Used in the Treatment of Skin Disorders
4. Development, validation, and application of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the estimation of Ropanicant in human plasma and urine
5. Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration
6. Usmarapride (SUVN-D4010), a 5-HT4 receptor partial agonist for the potential treatment of Alzheimer's disease: Behavioural, neurochemical and pharmacological profiling
7. Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects
8. Regression patterns of central serous chorioretinopathy using en face optical coherence tomography
9. Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
10. What is the Optimal Attribution Method for Explainable Ophthalmic Disease Classification?
11. What is the Optimal Attribution Method for Explainable Ophthalmic Disease Classification?
12. Annotation and segmentation of diabetic retinopathy lesions: an explainable AI application.
13. Safūf-i Aslussūs: A time-tested polyherbal formulation for the management of Premature Ejaculation- A comprehensive review
14. First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects
15. Classification and Quantification of Retinal Cysts in OCT B-Scans: Efficacy of Machine Learning Methods.
16. Absorption, distribution, metabolism, excretion (ADME), drug-drug interaction potential and prediction of human pharmacokinetics of SUVN-G3031, a novel histamine 3 receptor (H3R) inverse agonist in clinical development for the treatment of narcolepsy
17. Protecting Privacy While Improving Choroid Layer Segmentation in OCT Images: A GAN-Based Image Synthesis Approach
18. Association of reduced inner retinal thicknesses with chronic kidney disease
19. Choroidal hyper-reflective foci and vascularity in retinal dystrophy
20. Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses
21. Protecting Privacy while Improving Choroid Layer Segmentation in OCT Images: A GAN-based Image Synthesis Approach
22. Diurnal variation in subfoveal and peripapillary choroidal vascularity index in healthy eyes
23. Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
24. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy
25. Uncertainty aware and explainable diagnosis of retinal disease.
26. What is the Optimal Attribution Method for Explainable Ophthalmic Disease Classification?
27. Quantitative and Qualitative Evaluation of Explainable Deep Learning Methods for Ophthalmic Diagnosis.
28. Volumetric quantification of choroid and Haller's sublayer using OCT scans: An accurate and unified approach based on stratified smoothing.
29. Development of Standard Operating Procedures (SOPs) of a Polyherbal Formulation Qurṣ-i Muṣaffī Recommended for the Treatment of Skin Diseases
30. Biomarkers for central serous chorioretinopathy
31. Analysis of Choroidal Vascularity Index in Keratoconus Patients Using Swept-Source Optical Coherence Tomography-Based Binarization Techniques
32. Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
33. Optical coherence tomography angiography in acute unilateral nonarteritic anterior ischemic optic neuropathy: A comparison with the fellow eye and with eyes with papilledema
34. Change in choroidal vascularity in acute central serous chorioretinopathy
35. Effects of hydroxychloroquine therapy on choroidal volume and choroidal vascularity index
36. Benzamide derivatives and their constrained analogs as histamine H3 receptor antagonists
37. Choroidal Vascularity Map in Unilateral Central Serous Chorioretinopathy: A Comparison with Fellow and Healthy Eyes
38. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders
39. Development of Standard Operating Procedures (SOPs) of a Polyherbal Formulation Qurṣ-i Muṣaffī Recommended for the Treatment of Skin Diseases
40. Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease
41. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction
42. Automated quantification of Haller's layer in choroid using swept-source optical coherence tomography.
43. Multiproxy geochemical characterization of Kommugudem Formation, Krishna Godavari Basin, India: Implication on hydrocarbon potential and shale brittleness
44. En Face Choroidal Vascularity in Both Eyes of Patients with Unilateral Central Serous Chorioretinopathy
45. Choroidal vascularity profile in diabetic eyes using wide field optical coherence tomography
46. Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer’s Disease: A Post Hoc Analysis
47. Pulse wave analysis in hypertension treated with Unani herbal formulation UNIM 904 in comparison with standard drug amlodipine: A clinical study
48. Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study
49. Usmarapride Oxalate (SUVN‐D4010): A Serotonin‐4 Receptor Partial Agonist for the Treatment of Cognitive Disorders
50. Standardization and HPTLC fingerprinting of a potent Unani formulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.